Hunter Associates Investment Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.76M Buy
13,691
+1,817
+15% +$213K 0.2% 107
2026
Q1
$1.43M Buy
11,874
+219
+2% +$25.3K 0.19% 115
2025
Q4
$1.23M Buy
11,655
+35
+0.3% +$3.29K 0.16% 118
2025
Q3
$974K Buy
11,620
+176
+2% +$14.5K 0.14% 133
2025
Q2
$910K Buy
11,444
+2
+0% +$159 0.14% 131
2025
Q1
$1.03M Sell
11,442
-56
-0.5% -$5.23K 0.16% 121
2024
Q4
$1.14M Buy
11,498
+154
+1% +$15.9K 0.17% 113
2024
Q3
$1.29M Buy
11,344
+1
+0% +$119 0.2% 114
2024
Q2
$1.4M Sell
11,343
-57
-0.5% -$7.34K 0.24% 97
2024
Q1
$1.5M Buy
11,400
+2
+0% +$247 0.25% 96
2023
Q4
$1.25M Sell
11,398
-5,085
-31% -$528K 0.23% 102
2023
Q3
$1.7M Sell
16,483
-844
-5% -$91K 0.35% 64
2023
Q2
$2M Sell
17,327
-8,744
-34% -$993K 0.39% 61
2023
Q1
$2.77M Sell
26,071
-2,072
-7% -$224K 0.59% 44
2022
Q4
$3.12M Sell
28,143
-864
-3% -$88.3K 0.75% 38
2022
Q3
$2.5M Sell
29,007
-454
-2% -$40.5K 0.65% 45
2022
Q2
$2.68M Buy
29,461
+24,461
+489% +$2.17M 0.66% 42
2022
Q1
$410K Hold
5,000
0.13% 96
2021
Q4
$383K Hold
5,000
0.11% 105
2021
Q3
$376K Sell
5,000
-4,000
-44% -$304K 0.12% 104
2021
Q2
$700K Sell
9,000
-22,489
-71% -$1.67M 0.22% 75
2021
Q1
$2.32M Buy
31,489
+2,897
+10% +$214K 0.54% 49
2020
Q4
$2.23M Buy
28,592
+2,865
+11% +$219K 0.55% 48
2020
Q3
$2.04M Buy
25,727
+6,729
+35% +$527K 0.57% 42
2020
Q2
$1.4M Buy
18,998
+3,065
+19% +$231K 0.42% 56
2020
Q1
$1.17M Buy
15,933
+1,235
+8% +$97.1K 0.45% 51
2019
Q4
$1.28M Buy
14,698
+3,249
+28% +$267K 0.4% 59
2019
Q3
$920K Sell
11,449
-121
-1% -$9.7K 0.32% 67
2019
Q2
$926K Sell
11,570
-49
-0.4% -$3.75K 0.32% 66
2019
Q1
$922K Sell
11,619
-105
-0.9% -$7.85K 0.32% 67
2018
Q4
$855K Sell
11,724
-1,473
-11% -$104K 0.35% 65
2018
Q3
$893K Sell
13,197
-96
-0.7% -$6.12K 0.31% 69
2018
Q2
$770K Hold
13,293
0.28% 77
2018
Q1
$691K Buy
13,293
+105
+0.8% +$5.67K 0.26% 80
2017
Q4
$708K Buy
13,188
+105
+0.8% +$5.82K 0.26% 78
2017
Q3
$799K Sell
13,083
-419
-3% -$25.4K 0.31% 67
2017
Q2
$826K Hold
13,502
0.34% 64
2017
Q1
$819K Sell
13,502
-27
-0.2% -$1.64K 0.34% 64
2016
Q4
$760K Buy
13,529
+573
+4% +$33.5K 0.32% 68
2016
Q3
$772K Sell
12,956
-509
-4% -$29.8K 0.33% 71
2016
Q2
$740K Hold
13,465
0.32% 73
2016
Q1
$680K Buy
13,465
+812
+6% +$39.8K 0.31% 76
2015
Q4
$638K Hold
12,653
0.28% 76
2015
Q3
$596K Buy
12,653
+210
+2% +$11.2K 0.28% 83
2015
Q2
$676K Hold
12,443
0.28% 84
2015
Q1
$682K Sell
12,443
-419
-3% -$23.7K 0.27% 90
2014
Q4
$697K Hold
12,862
0.27% 85
2014
Q3
$728K Hold
12,862
0.28% 80
2014
Q2
$710K Sell
12,862
-1,222
-9% -$66.7K 0.28% 81
2014
Q1
$763K Hold
14,084
0.3% 78
2013
Q4
$673K Sell
14,084
-2
-0% -$91 0.26% 81
2013
Q3
$640K Sell
14,086
-3,669
-21% -$168K 0.27% 79
2013
Q2
$787K Buy
+17,755
New +$793K 0.29% 79

Other funds holding MRK

Hunter Associates Investment Management's MRK Position: Q2 2026 in Review

Hunter Associates Investment Management increased its Merck (MRK) stake by 15% in Q2 2026, buying an estimated $213K and bringing the position to 13,691 shares worth $1.76M. The position accounts for 0.2% of the portfolio, ranked #107.

Hunter Associates Investment Management first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.12M in Q4 2022. 1,563 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Hunter Associates Investment Management held 13,691 shares of Merck worth $1.76M as of Q2 2026.
  • Hunter Associates Investment Management bought 1,817 Merck shares in Q2 2026, an estimated $213K.
  • Merck made up 0.2% of Hunter Associates Investment Management's portfolio in Q2 2026, its #107 holding.
  • Hunter Associates Investment Management first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
  • Hunter Associates Investment Management's Merck position peaked at $3.12M in Q4 2022.
  • 1,563 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Hunter Associates Investment Management's 13F filing for Q2 2026, filed 23 Jul 2026.